Aligos Therapeutics, Inc. (ALGS) vs Seres Therapeutics, Inc. (MCRB)
- Aligos Therapeutics, Inc. ALGS 2.10 +6.06%
- Seres Therapeutics, Inc. MCRB 1.40 −0.71%
Aligos Therapeutics, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Seres Therapeutics, Inc. are of similar size ($14.4M and $14.0M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 1,171.6% against −98.3%. Aligos Therapeutics, Inc. has the higher net margin (−197.0% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 15 metrics below, Aligos Therapeutics, Inc. leads on 11 and Seres Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ALGS | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 67.24% |
| Operating margin | (215.55%) | (3,656.89%) | 0.00% |
| Net margin | (197.01%) | (2,209.55%) | 0.00% |
| Free cash flow margin | (204.07%) | (2,997.74%) | 0.00% |
| Return on equity | (159.46%) | (144.35%) | (50.28%) |
| Return on assets | (84.46%) | (44.85%) | (45.89%) |
| Return on invested capital | 0.00% | (1,267.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack